Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Alemtuzumab use may reduce tacrolimus toxicity in liver transplantation

May 25, 2004

ISA-247 more potent than ciclosporin in renal transplant recipients

May 25, 2004

FK-778 results presented at American transplantation congress

May 25, 2004

Novel selective S1P receptor agonist shows prolonged effect in animal transplant models

May 24, 2004

Small molecule Lck inhibitors promote long-term allograft survival

May 24, 2004

Novel CCR5 antagonists for transplant rejection, autoimmune diseases, etc.

May 21, 2004

Phase II/III trial of AIC for treatment of ragweed allergy now fully enrolled

May 21, 2004

Isotechnika receives clearance to initiate phase I trial of TAFA-93 in Canada

May 21, 2004

Largest-ever trial begins to evaluate efficacy and safety of IGIV for CIDP

May 20, 2004

3M scientists develop immune response modifiers for use in viral infections and cancer

May 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...